Drawing for AG OXYSALTS

USPTO serial 88585756

AG OXYSALTS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WOOD, CAROLINE
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AG OXYSALTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pamela B. Huff

Pamela B. Huff SCHWEGMAN LUNDBERG & WOESSNER P.A.P.O. BOX 2938MINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; medicated, sanitary or disinfecting preparations for the treatment of the feet, body and skin for use in association with acute and chronic wounds; medicinal and therapeutic preparations for the cleaning and debridement of wounds; disinfectant preparations for skin care being all purpose disinfectants, antiseptics, antifungal preparations; pharmaceutical preparations and medicated skin preparations for the treatment of scars and scars related skin conditions; medicated or pharmaceutical preparations for treating corns and chilblains; medicated preparations for curing ingrown toe-nails; medicated pads for the prevention of inflammation of the toes and of the thickening of skin calluses; wound dressings and materials for wound dressings, namely, absorbent pads for skin wounds; medical wound dressings for use in cleansing wounds, exfoliating skin and wounds and removing debris from skin and wounds; medicated bandages and dressings for the treatment of skin wounds, burns, diabetic ulcers, pressure ulcers, surgical wounds, vascular and circulatory system related skin diseases; medical bandages in the shape of a boot for dressing foot wounds; medical plasters for protecting, cushioning and moisturizing corns and blisters; medicated pads for the prevention of inflammation of the toes and of the thickening of skin calluses; medicated pads and insoles; bandages and dressings for the treatment of the skin impregnated with anti-fungal preparations and antimicrobial preparations and substances; dressings for the management of exudate from wounds; medical dressings; medical materials for dressings, namely, plasters, plaster rings, rings for corns being plasters; non-woven polyester medical dressings; non-woven medical dressings; foam wound dressings; absorptive foam dressings and pads for wound care; adhesive non-woven fabric being bandages for application and fixation of dressings; self-adhesive dressings; surgical dressings; gauze for dressings; bandages for dressings; pharmaceutical preparations for the treatment of wounds and skin wounds, namely, foils, meshes, compresses, permeable plastic films; medicated compresses; medicated cleansing pads for the skin; medicated absorbent pads for skin wounds; dressings and pads incorporating anti- fungal preparations; dressings and pads incorporating antimicrobial substances for dermatologic use; anti-fungal sprays; antibacterial sprays; bandages for skin wounds; all-purpose disinfectants; antiseptic preparations; sanitizing wipes; anti-fungal preparations; antimicrobial preparations for inhibiting and preventing bacteria; antimicrobials for dermatologic use; medical materials for dressings, namely, gauze, foam pads for medical purposes, hydrogel pads for medical purposes, hydrocolloid pads for medical purposes, medical adhesive and non-adhesive tape for retention and fixation of dressings, non-woven fabric being adhesive bandages for application and fixation of dressings; disinfectant preparations and antiseptic products, namely, wipes, tissues, sponges impregnated with disinfectant, sanitizing or antiseptic preparations; bandages for skin wounds; antimicrobial metal coatings for medical and dental applications; antimicrobial metal powders, foils, paints and coatings for medical, dental, wound and burn dressings applications; chemicals and chemical products and compounds for medical purposes, namely, chemical contraceptives; all of the foregoing containing silver as an ingredient; none of the above for the prevention or treatment of acneACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 22, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 22, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 14, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2022EX2GSOU EXTENSION 2 GRANTED—
Jan 12, 2022EXT2SOU EXTENSION 2 FILED—
Jan 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 20, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 16, 2021EX1GSOU EXTENSION 1 GRANTED—
Jul 16, 2021EXT1SOU EXTENSION 1 FILED—
Jul 16, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2021CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Apr 13, 2021APETASSIGNED TO PETITION STAFF—
Jan 19, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 28, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 24, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 24, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 6, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2020ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 21, 2020PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 6, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 15, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jun 15, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 15, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 15, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
May 26, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 26, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 26, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2019DOCKASSIGNED TO EXAMINER—
Sep 23, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 18, 2019ALIEASSIGNED TO LIE—
Sep 12, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 6, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 5, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 23, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance